OUR PRODUCTS

MOBILE APPS

GENERAL INFO

KNSA

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Kiniksa Pharmaceuticals International (KNSA) Earnings Date & Reports

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

KNSA is expected to report earnings to rise 36.48% to 31 cents per share on November 04

Kiniksa Pharmaceuticals International KNSA Stock Earnings Reports

Q3'25

Est.

$0.31

Q2'25

Beat

by $0.04

Q1'25

Beat

by $0.09

Q4'24

Missed

by $0.14

Q3'24

Missed

by $0.19

The last earnings report on July 29 showed earnings per share of 23 cents, beating the estimate of 18 cents. With 168.84K shares outstanding, the current market capitalization sits at 2.38B.

View a ticker or compare two or three

Compare

KNSA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For KNSA
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. KNSA showed earnings on July 29, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsGeneric

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

2 Church Street

Phone

+44 8081896257

Employees

297

Web

https://www.kiniksa.com